Page 157 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 157
YI P0210 COMBINED PARTIAL SPLENIC EMBOLIZATION (PSE) ePOSTERS
YI P0211 ALLOWS REDUCING TRANSJUGULAR INTRAHEPATIC
YI P0212 PORTOSYSTEMIC SHUNT (TIPS) DIAMETER IN
YI P0213 HYPERSPLENIC CIRRHOTIC PATIENTS: A PILOT STUDY
YI P0214 David Regnault*, Arnaud Geffray, Charlotte Nicolas, Louis D’alteroche,
Julien Pucheux, Mauricio Sainz Barriga, Petru Bucur, Ephrem Salame,
Jean-Marc Perarnau, France
HUMAN MICROFIBRIL–ASSOCIATED PROTEIN 4 (MFAP4)
IN ASCITES FLUID PREDICT SURVIVAL AND RISK
OF COMPLICATIONS IN PATIENTS WITH ADVANCED
CIRRHOSIS
Maria Kjaergaard*, Bjørn S. Madsen, Maja Thiele, Axel Malchow-Møller,
Anders Schlosser, Grith L. Sørensen, Uffe Holmskov, Aleksander Krag,
Denmark
IDENTIFYING THE TRIGGER MATTERS – OUTCOME
OF SEVERE ACUTE KIDNEY INJURY IN PATIENTS WITH
CIRRHOSIS AND ASCITES
Theresa Bucsics*, Mattias Mandorfer, Philipp Schwabl, Simona Bota,
Michael Trauner,Wolfgang Sieghart, Arnulf Ferlitsch, Markus Peck-
Radosavljevic,Thomas Reiberger, Austria
DIABETES IS A MAJOR DETERMINANT FOR REFRACTORY
ASCITES IN PATIENTS WITH CIRHOSIS AND IS
ASSOCIATED WITH HEPATIC MICROCIRCULATORY
CHANGES
Laure Elkrief*, Sophie Buyse, Xavière Panhard, Clotilde Baudry,
Richard Moreau, Pierre-Emmanuel Rautou, Jacques Belghiti,
François Durand, Pierre Bedossa, Dominique Valla, Valérie Paradis,
France
PREDICTORS OF RESPONSE AND OUTCOME TO
TERLIPRESSIN IN PATIENTS WITH HEPATORENAL
SYNDROME
Shah Vinit*, Ashish Kumar, Praveen Sharma, Rinkesh K. Bansal,
Pankaj Tyagi, Naresh Bansal, Vikas Singla, Mandhir Kumar,
Piyush Ranjan, Munish K. Sachdeva, Anil Arora, India
Vienna, Austria • April 22–26, 2015 157
YI P0211 ALLOWS REDUCING TRANSJUGULAR INTRAHEPATIC
YI P0212 PORTOSYSTEMIC SHUNT (TIPS) DIAMETER IN
YI P0213 HYPERSPLENIC CIRRHOTIC PATIENTS: A PILOT STUDY
YI P0214 David Regnault*, Arnaud Geffray, Charlotte Nicolas, Louis D’alteroche,
Julien Pucheux, Mauricio Sainz Barriga, Petru Bucur, Ephrem Salame,
Jean-Marc Perarnau, France
HUMAN MICROFIBRIL–ASSOCIATED PROTEIN 4 (MFAP4)
IN ASCITES FLUID PREDICT SURVIVAL AND RISK
OF COMPLICATIONS IN PATIENTS WITH ADVANCED
CIRRHOSIS
Maria Kjaergaard*, Bjørn S. Madsen, Maja Thiele, Axel Malchow-Møller,
Anders Schlosser, Grith L. Sørensen, Uffe Holmskov, Aleksander Krag,
Denmark
IDENTIFYING THE TRIGGER MATTERS – OUTCOME
OF SEVERE ACUTE KIDNEY INJURY IN PATIENTS WITH
CIRRHOSIS AND ASCITES
Theresa Bucsics*, Mattias Mandorfer, Philipp Schwabl, Simona Bota,
Michael Trauner,Wolfgang Sieghart, Arnulf Ferlitsch, Markus Peck-
Radosavljevic,Thomas Reiberger, Austria
DIABETES IS A MAJOR DETERMINANT FOR REFRACTORY
ASCITES IN PATIENTS WITH CIRHOSIS AND IS
ASSOCIATED WITH HEPATIC MICROCIRCULATORY
CHANGES
Laure Elkrief*, Sophie Buyse, Xavière Panhard, Clotilde Baudry,
Richard Moreau, Pierre-Emmanuel Rautou, Jacques Belghiti,
François Durand, Pierre Bedossa, Dominique Valla, Valérie Paradis,
France
PREDICTORS OF RESPONSE AND OUTCOME TO
TERLIPRESSIN IN PATIENTS WITH HEPATORENAL
SYNDROME
Shah Vinit*, Ashish Kumar, Praveen Sharma, Rinkesh K. Bansal,
Pankaj Tyagi, Naresh Bansal, Vikas Singla, Mandhir Kumar,
Piyush Ranjan, Munish K. Sachdeva, Anil Arora, India
Vienna, Austria • April 22–26, 2015 157